Byung Guk Yang – CEO, Daewoong Bio, South Korea
Dr Byung Guk Yang, CEO of Daewoong Bio, explains the challenges the Korean healthcare system is facing and how his…
Korean Pharmaceutical Association (KPA)
Last updated: 11.11.2014
Korean Pharmaceutical Association (KPA) is a non-profit organization established as Korea Pharmacists Association in 1928. Approximately 60,000 members of KPA have contributed to public health through ‘good quality of medicine and right medication’. With our belief and willingness to improve public health, members of KPA are committed to build a welfare country.
KPA has 16 regional divisions (5 special divisions abroad), 227 branches, General Assembly of Delegates as a legislative body, and 16 standing committees as an executive organization.
KPA has made efforts that pharmacies as the closest health care provider offer good quality of public health care service. KPA has tried to keep the policy of separation of dispensary from medical practice, offer on-going education to pharmacists, renovate and develop pharmacology, improve national health insurance, establish fair trade of medical supplies, promote an information-oriented pharmacology, and build a computerized pharmacy.
In addition, KPA supports various social programs and makes efforts to build social safety networks such as smoking cessation campaign, child protection program, 1388 youth protection campaign, and more.
KPA will try to develop public health service system combining public interests with pharmacists’ right and do the best effort to complete roles of pharmacists under the slogan of ‘pharmacists with pride. KPA in company with public’.
Contact details
Address: 1493-3 Seocho-3 Dong, Seocho-gu, Seoul 137-869 KOREA
Tel: +82 02 581 1201
www.kpanet.or.kr
Related
YJ Kim – Country Manager, BD Korea
YJ Kim, country manager at BD Korea, discusses the integration of Bard into BD at the local level. He also offers…
Seok Joo Lee – CEO, ISU Abxis, South Korea
ISU Abxis, a subsidiary of the ISU conglomerate, is a biotech company with a focus on orphan drugs and rare…
Sora Lee – Vice President & General Manager Korea, Syneos Health
Syneos Health, established through a merger in 2017, has held a foothold in Korea through its legacy organisations…
Jeong Woo Cho – CEO & President, SK Biopharmaceuticals & SK Life…
SK Group, the second largest conglomerate in South Korea and renowned as a leader in energy, telecommunications,…
Bong Gil Nam – Chairman & Owner, Pharmbio Korea
Bong Gil Nam, chairman and owner of Pharmbio Korea, offers his insights on his company’s importance in…
Han-Oh Park – President, Founder and CEO, Bioneer, South Korea
Bioneer, founded in 1992, lays claim to be Korea’s oldest biotechnology company. President, founder and CEO, Dr…
H. Samuel Muk – President & CEO, Korea Drug Development Fund (KDDF)
The Korea Drug Development Fund (KDDF) is a government-funded organization created to accelerate innovation…
Nam Han Cho – President, International Diabetes Federation, South Korea
Dr Nam Han Cho, president of the International Diabetes Federation (IDF) and professor of Preventive Medicine at…
Korea to Strengthen Support for Rare Disease Patients
This week, the Korean Ministry of Food and Drug Safety announced that it would enhance drug safety management and…
Korean Healthcare and Pharma’s 10-Year Plan
The administration of President Moon Jae-in is moving to ensure the enduring success of South Korea’s healthcare…
Narihiko Yoshii – President, Mitsubishi Tanabe Pharma Korea
Narihiko Yoshii, president of Mitsubishi Tanabe Pharma Korea unveils the value that they are bringing to Korean…
